Catalyst Says FDA Is Breaking Law By Approving Rival's Drug
By Carolina Bolado · September 22, 2020, 5:02 PM EDT
Catalyst Pharmaceuticals Inc. fought Tuesday against a federal judge's determination that the U.S. Food and Drug Administration lawfully approved a lower-cost version of a drug that treats a rare autoimmune disease,...
To view the full article, register now.